Norman Ratcliffe

Prof. Dr. Norman Ratcliffe

Centre for Research in Analytical, Materials, and Sensor Sciences, University of the West of England, Coldharbour Lane, Bristol BS16 1QY, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in Journal of Breath Research
Verified
Journal Article
Closed access
PDF file
Natalia DrabińskaNatalia Drabińska
Natalia Drabińska
CFCheryl Flynn
Cheryl Flynn
Norman RatcliffeNorman Ratcliffe
Norman Ratcliffe
Ilaria BelluomoIlaria Belluomo
Ilaria Belluomo
Antonis MyridakisAntonis Myridakis
Antonis Myridakis
BCBen De Lacy Costello
Ben De Lacy Costello
This paper comprises an updated version of the 2014 review which reported 1846 volatile organic compounds (VOCs) identified from healthy humans. In total over 900 additional VOCs have been reported since the 2014 review and the VOCs from semen have been added. The numbers of VOCs found in breath and the other bodily fluids are: blood 379, breath 1488, faeces 443, milk 290, saliva 549, semen 196, skin 623 and urine 444. Compounds were assigned CAS registry numbers and named according to a common convention where possible. The compounds have been included in a single table with the source reference(s) for each VOC, an update on our 2014 paper. VOCs have also been grouped into tables according to their chemical class or functionality to permit easy comparison. Careful use of the database is needed, as a number of the identified VOCs only have level 2—putative assignment, and only a small fraction of the reported VOCs have been validated by standards. Some clear differences are observed, for instance, a lack of esters in urine with a high number in faeces and breath. However, the lack of compounds from matrices such a semen and milk compared to breath for example could be due to the techniques used or reflect the intensity of effort e.g. there are few publications on VOCs from milk and semen compared to a large number for breath. The large number of volatiles reported from skin is partly due to the methodologies used, e.g. by collecting skin sebum (with dissolved VOCs and semi VOCs) onto glass beads or cotton pads and then heating to a high temperature to desorb VOCs. All compounds have been included as reported (unless there was a clear discrepancy between name and chemical structure), but there may be some mistaken assignations arising from the original publications, particularly for isomers. It is the authors’ intention that this work will not only be a useful database of VOCs listed in the literature but will stimulate further study of VOCs from healthy individuals; for example more work is required to confirm the identification of these VOCs adhering to the principles outlined in the metabolomics standards initiative. Establishing a list of volatiles emanating from healthy individuals and increased understanding of VOC metabolic pathways is an important step for differentiating between diseases using VOCs.

1 October 2011 in Insect Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
Norman RatcliffeNorman Ratcliffe
Norman Ratcliffe
CMCicero B. Mello
Cicero B. Mello
EGEloi S. Garcia
Eloi S. Garcia
TBTariq Butt
Tariq Butt
PAPatricia Azambuja
Patricia Azambuja

25 January 2016 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
IAI. Ahmed
I. Ahmed
RGR. Greenwood
R. Greenwood
BCB. Costello
B. Costello
Norman RatcliffeNorman Ratcliffe
Norman Ratcliffe
CPC. S. Probert
C. S. Probert

13 May 2020 in Journal of Breath Research
Verified
Journal Article
Closed access
PDF file
Norman RatcliffeNorman Ratcliffe
Norman Ratcliffe
TWThomas Wieczorek
Thomas Wieczorek
Natalia DrabińskaNatalia Drabińska
Natalia Drabińska
OGOliver Gould
Oliver Gould
AOAlan Osborne
Alan Osborne
BCBen De Lacy Costello
Ben De Lacy Costello
The assessment of volatile compounds (VOCs) for disease diagnosis is a growing area of research. There is a need to provide hard evidence i.e. biochemical routes, to justify putative VOC biomarkers, as in many cases this remains uncertain, which weakens their authenticity. Recently reports of volatile hydrocarbons and or aldehydes in bodily fluids and breath have been attributed to oxidative stress, although as discussed here, fewer compounds have been reported than expected from a mechanistic examination. Oxidative stress can result from many disease states which produce inflammation, and a better understanding of the interconnection between oxidative stress and the release of VOCs from target diseased and healthy organs could greatly help diagnoses. It is generally considered that oxidation of unsaturated fatty acids are a major source of these VOCs. An investigation listing the many possible volatile oxidation products has not been undertaken. This is described here using a mechanistic analysis (based on the literature) of the compounds derived from molecular cleavage and the results compared with a recent review of all the VOCs emanating from the human body, which satisfactorily explains the presence of at least 100 VOCs. Six important unsaturated fatty acids, oleic, palmitoleic, linoleic, linolenic, arachidonic, and cervonic acids have been shown to be capable of producing up to 18 n+6 unique breakdown products (where n = the number of alkene double bonds in the fatty acid hydrocarbon chain), in total 299 compounds. In many cases these have not been reported. We suggest several reasons for this: these VOCs have not been expected, so researchers are not looking for them and importantly some are not present in the mass spectral libraries, or they are too low a concentration to have been detected, or are not present. Furthermore a theoretical explanation for the origins of branched aldehydes and other compounds arising from bacterial oxidative metabolism of unsaturated fatty acids are described.

31 March 2022 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
Norman RatcliffeNorman Ratcliffe
Norman Ratcliffe
JPJoão P. Furtado Pacheco
João P. Furtado Pacheco
PDPaul J. Dyson
Paul J. Dyson
HCHelena Carla Castro
Helena Carla Castro
LSLilia Serodio
Lilia Serodio
CMCicero B. Mello
Cicero B. Mello
This article presents an overview of paratransgenesis as a strategy to control pathogen transmission by insect vectors. It first briefly summarises some of the disease-causing pathogens vectored by insects and emphasises the need for innovative control methods to counter the threat of resistance by both the vector insect to pesticides and the pathogens to therapeutic drugs. Subsequently, the state of art of paratransgenesis is described, which is a particularly ingenious method currently under development in many important vector insects that could provide an additional powerful tool for use in integrated pest control programmes. The requirements and recent advances of the paratransgenesis technique are detailed and an overview is given of the microorganisms selected for genetic modification, the effector molecules to be expressed and the environmental spread of the transgenic bacteria into wild insect populations. The results of experimental models of paratransgenesis developed with triatomines, mosquitoes, sandflies and tsetse flies are analysed. Finally, the regulatory and safety rules to be satisfied for the successful environmental release of the genetically engineered organisms produced in paratransgenesis are considered. Graphical Abstract

1 May 2001 in Experimental Parasitology
Verified
Journal Article
Closed access
MWM.M.A. Whitten
M.M.A. Whitten
CMC.B. Mello
C.B. Mello
SGS.A.O. Gomes
S.A.O. Gomes
YNY. Nigam
Y. Nigam
PAP. Azambuja
P. Azambuja
Norman RatcliffeNorman Ratcliffe
Norman Ratcliffe